NOV
Asset Logo

Novatti Group Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿค– TECHNOLOGY

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-16.32%
Annual Growth

5 years average annual growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

17
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Novatti Group Ltd. provides software technology and systems integration services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2016-01-18. The Companyโ€™s segments include Technology, Business automation, Acquiring, Alternative payments, Banking services, Issuing, and ATX payments. Technology segment develops, deploys, and supports specialized mobile and alternate payment technology, primarily through the deployment of the Novatti Wallet Platform. Business automation segment automates business processes, including customer engagement, subscription management and embedded payments. Acquiring segment accepts a range of payments. Alternative payments segment includes bill payments for international and local university and college students. Banking services segment offers customers an alternative payment method in the form of a prepaid cash voucher. Issuing segment provides a payment system centered around digital and physical prepaid, gift and debit cards for a variety of fintechs and commercial enterprises. ATX payments segment provides a payments network across Malaysia.

๐Ÿ“ˆ Performance

Price History

-82.15%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.04

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in NOV

17

๐Ÿ“Š Total Capital Earnings

$4K

๐Ÿ”ƒ Average investment frequency

44 weeks

๐Ÿ’ต Average investment amount

$1,058

โฐ Last time a customer invested in NOV

15 days
NOV investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

37%

50k - 100k

21%

Less than 50k

32%
๐Ÿ‘ถ Age of investors

18 - 25

18%

26 - 34

12%

35 - 90

71%
๐Ÿ™‹ Legal gender of investors

Female

35%

Male

65%

Pearlers who invest in NOV also invest in...

NOVN

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

3.85%

๐Ÿ“Š Share price

$100.90 AUD

โ›ณ๏ธ DIVERSIFIED

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

๐Ÿงฑ MATERIALS

๐Ÿ’ธ FINANCIALS

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

3.71%

๐Ÿ“Š Share price

$66.50 AUD

๐ŸŒ GLOBAL

โ›ณ๏ธ DIVERSIFIED

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

12.86%

๐Ÿ“Š Share price

$129.54 AUD

๐ŸŒ GLOBAL

โ›ณ๏ธ DIVERSIFIED

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 493.8m in AUM and 35 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

๐Ÿ™Œ Performance (5Yr p.a)

13.46%

๐Ÿ“Š Share price

$82.57 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

๐Ÿญ INDUSTRIALS

Want more shares? Try these...

๐Ÿ“Š Share price

$0.01 AUD

Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Castle Hill, New South Wales and currently employs 1,000 full-time employees. The company went IPO on 2016-08-09. The company is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. The company utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

๐Ÿ™Œ Performance (5Yr p.a)

-14.20%

๐Ÿ“Š Share price

$0.10 AUD

๐Ÿงฌ BIOTECHNOLOGY

Noumi Ltd. engages in the manufacture and sale of food products. The firm produces dairy and plant-based beverages, nutritional products and ingredients that are used in the health and fitness industries. Its segments include Dairy and Nutritionals, and Plant-based Milks. The Dairy and Nutritionals segment includes a range of long-life dairy milk beverage, nutritional products and performance and adult nutritional powders. The Plant-based Milks segment includes a range of long-life beverage products including almond, soy, oat, coconut, macadamia and other plant-based milks plus liquid stocks. The company operates manufacturing facilities in Victoria and New South Wales and produces key brands including the MILKLAB range of shelf-stable dairy and plant-based milks, Australia's Own, So Natural, Crankt, Vital Strength and PUREnFERRIN lactoferrin. The firm sells its products to retailers and distributors in Australia, China, Southeast Asia, New Zealand, South Africa and the Middle East.

๐Ÿ™Œ Performance (5Yr p.a)

-19.09%

๐Ÿ“Š Share price

$0.24 AUD

๐Ÿ” FOOD PRODUCTS

๐Ÿ“Š Share price

$0.01 AUD
Compare
Add to watchlist